GIORDANI, JORDAN
 Distribuzione geografica
Continente #
NA - Nord America 2.349
AS - Asia 1.415
EU - Europa 1.196
SA - Sud America 316
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.316
Nazione #
US - Stati Uniti d'America 2.276
SG - Singapore 665
IT - Italia 417
CN - Cina 281
BR - Brasile 256
DE - Germania 162
FI - Finlandia 140
HK - Hong Kong 118
VN - Vietnam 101
FR - Francia 75
GB - Regno Unito 70
IN - India 64
IE - Irlanda 61
TR - Turchia 54
RU - Federazione Russa 52
CA - Canada 36
BE - Belgio 34
SE - Svezia 33
UA - Ucraina 32
ID - Indonesia 26
PL - Polonia 26
AR - Argentina 25
JP - Giappone 18
MX - Messico 18
BD - Bangladesh 17
ZA - Sudafrica 17
AT - Austria 14
NL - Olanda 13
IQ - Iraq 11
EC - Ecuador 10
ES - Italia 10
PK - Pakistan 10
VE - Venezuela 10
MK - Macedonia 9
LT - Lituania 8
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 5
CO - Colombia 5
MA - Marocco 5
NP - Nepal 5
AZ - Azerbaigian 4
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
PA - Panama 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
LV - Lettonia 3
NO - Norvegia 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AU - Australia 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.315
Città #
Ashburn 349
Singapore 334
Chandler 228
San Jose 187
Brescia 168
New York 147
Hong Kong 116
Fairfield 87
Helsinki 85
Los Angeles 85
The Dalles 76
Princeton 74
Beijing 68
Munich 65
Lauterbourg 48
Wilmington 46
Seattle 44
Milan 43
Verona 43
Woodbridge 42
Turku 41
Dublin 40
Ho Chi Minh City 38
Istanbul 38
Ann Arbor 34
Brussels 34
Cambridge 34
Dallas 33
Shanghai 32
Houston 31
São Paulo 27
Council Bluffs 25
Warsaw 25
San Francisco 23
Hanoi 22
Jakarta 22
Chicago 21
Redondo Beach 21
Moscow 19
Montreal 18
Washington 18
Buffalo 17
Chennai 16
Tokyo 16
Trento 16
Brooklyn 15
Düsseldorf 15
Azzano 14
Denver 14
Lappeenranta 14
Menlo Park 14
Orem 14
Santa Clara 14
Atlanta 13
Boardman 13
Jacksonville 13
Phoenix 13
Frankfurt am Main 12
London 12
Pune 12
San Diego 12
Des Moines 11
Johannesburg 10
Mumbai 9
Nuremberg 9
Sommacampagna 9
Stockholm 9
Poplar 8
Rome 8
Skopje 8
Ankara 7
Boston 7
Mexico City 7
Paris 7
Romola 7
Vienna 7
Belo Horizonte 6
Cazzago San Martino 6
Gunzenhausen 6
Kyiv 6
Portsmouth 6
Amsterdam 5
Guangzhou 5
Hangzhou 5
Islington 5
Bergamo 4
Gurugram 4
Lima 4
Manchester 4
Philadelphia 4
Piangipane 4
Riga 4
Rio de Janeiro 4
São João del Rei 4
Tashkent 4
Toronto 4
Augusta 3
Baghdad 3
Baku 3
Brasília 3
Totale 3.439
Nome #
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 166
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 165
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 156
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 146
Consequences of SARS-COV-2 Pneumonia on Lung function 144
A case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) with thrombosis of the superior mesenteric artery after ChAdOx1 nCov-19 COVID-19 Vaccine 138
Alpha1-antitrypsin deficiency and asthma 137
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 136
Predictors of exercise-induced airways obstruction in patients with mild asthma 134
Phenotyping OSAH patients during wakefulness 133
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 129
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 128
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 128
Ultrasonographic Evaluation of Subglottic Stenoses: A Preliminary Analysis 125
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 124
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 123
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 122
Evaluating the Respiratory Function Impairments in Patients with Previous SARS-COV2 Pneumonia 120
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 117
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 117
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 117
Effects of short-term exposure to particulate matter on emergency department admission and hospitalization for asthma exacerbations in Brescia district 114
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 113
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 111
EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA 109
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 108
Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation 107
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 107
Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients 106
Evaluation of a New Strategy to Predict Exercise-Induced Asthma 105
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 104
Benralizumab therapy rapidly improved the quality of life in a woman with adult-onset non-allergic eosinophilic asthma 103
Assessment of respiratory function and exercise tolerance at 4-6 months after COVID-19 infection in patients with pneumonia of different severity 103
Simplified Daytime Approach in OSAH Phenotyping 101
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 99
PHENOTYPING PATIENTS WITH OSAH DURING WAKEFULNESS 98
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 98
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 97
Short-Term Exposure to Particulate Matter and Asthma: A Link Between Environment and Respiratory Emergencies 97
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development? 97
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 96
Sleep-disordered breathing and pregnancy outcomes: The impact of maternal oxygen saturation 85
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 82
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 82
Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia 80
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up 75
Deficit Di Alfa-1 Antitripsina E Bpco: I Danni Del Ritardo Diagnostico 55
Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment 48
24-Month assessment of respiratory function in patients hospitalized for severe SARS-CoV-2 pneumonia: a follow-up study 34
Totale 5.419
Categoria #
all - tutte 29.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 33 87 25
2021/2022447 28 14 32 54 7 50 32 39 37 32 38 84
2022/2023599 51 77 31 47 35 115 2 110 55 0 20 56
2023/2024592 32 11 65 78 34 171 11 55 71 10 6 48
2024/20251.144 2 17 10 152 101 97 65 47 184 146 178 145
2025/20262.251 238 261 140 382 311 187 354 70 141 167 0 0
Totale 5.419